Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung CancerG. Frasci, Mario De Lena, Vito Lorusso et al.|Journal of Clinical Oncology|2000Cited by 452
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology GroupPasquale Comella, Giuseppe Comella, G. Frasci et al.|Journal of Clinical Oncology|2000Cited by 177
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experienceImmacolata Capasso, Antonio Giordano, Emanuela Esposito et al.|Cancer Biology & Therapy|2010Cited by 108
Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology GroupPasquale Comella, Giuseppe Comella, G. Frasci et al.|Journal of Clinical Oncology|1999Cited by 73
Cisplatin, Gemcitabine, and Paclitaxel in Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: A Phase I-II StudyG. Frasci, Giuseppe Comella, Nicola Panza et al.|Journal of Clinical Oncology|1999Cited by 54